IMRIS enters into a secured loan facility for $25 million
Commented Jay D. Miller, IMRIS president and chief executive officer: “We are pleased with Deerfield’s confidence in our cutting-edge technology, growth prospects and business strategy. IMRIS has a compelling line-up of FDA-approved and development-stage products for the surgical theater that will provide a strong foundation for future growth. This agreement provides capital to fund our growth initiatives, strengthen our balance sheet and enable us to focus on developing a world-class medical device company.”